Get Brochure


Regulatory Services in Colombia

Regulatory Compliance Experts in Colombia

The Colombia National Food and Drug Surveillance Institute, or Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), was established in 1992 under the Ministry of Health to regulate drugs, medical devices , and biologics in the country. Local authorities periodically conduct inspections as a result of anonymous complaints or authoritative instructions to ensure compliance with regulation is met. Due to the comprehensive analysis regime, the INVIMA can take comparatively longer in granting a marketing authorization. For an innovator product, the authorization process is longer compared to a generic or drug that is listed on the Official Pharmacopeia. Similarly, the authorization time may be longer for biologics and biosimilars unless abbreviated routes are allowed, depending on the molecule, that could accelerate the process of obtaining marketing authorization.

As a leading global contender, DDReg’s regulatory services in Colombia provide ongoing support and development of customized strategies during all regulatory phases while keeping track of the most recent regulatory requirements to ensure high quality and timely submissions. We deliver reliable safety measures, ensure risk mitigation, and collaborate with experts to facilitate effortless delivery of product launches, regulatory filings, and market authorizations.

Our Regulatory Consulting Services In Colombia Portfolio Covers

  • Regulatory Strategies and Expert Views
  • Regulatory Due Diligence
  • Gap Analysis and Remediation
  • New Product Authorizations
  • Post Approval Life Cycle Management
  • CMC Advisory
  • API -DMF

Our Regulatory Affairs Consulting Services portfolio covers:


Regulatory Strategies / Expert Views

Regulations pertaining to pharmaceutical products are continuously changing...

Read More➔

New Product Authorizations

Pharmaceuticals and other medicinal products need to be prior authorized by...

Read More➔

Gap Analysis and Remediation

A gap analysis is a regulatory review process that identifies data gaps in the technical...

Read More➔

Regulatory Due Diligence

Regulatory issues arise unexpectedly and can create significant strain on a company’s...

Read More➔


DDReg provides expert consulting and efficient services for quality Drug Substance...

Read More➔

CMC Advisory

When it comes to regulatory strategies, CMC documentation play a crucial role in developing...

Read More➔

Post Approval Life Cycle Management

Managing the post-approval life cycle of a product is an essential component to sustaining...

Read More➔
Regulatory Certification

Regulatory Certification

Administrative documents are an integral component of regulatory submissions and constitute key certifications...

Read More➔
Regulatory Certification

ANDA and MA Holder Services

The regulatory approval pathway for Abbreviated New Drug Applications (ANDAs) is relatively complex....

Read More➔
Contact our experts today !
Country Specific Services

How can we help you?
Call us on:+1 (302) 601-2755